Mitochondrial health parameters as clinical predictors of Parkinson's disease
Abstract:
Methods are disclosed for detecting peripheral mitochondrial DNA damage and dysfunction. Methods are also disclosed that utilize blood samples to detect a neurodegenerative disease, such as Parkinson's disease, and determine the efficacy of therapy.
Information query
Patent Agency Ranking
0/0